The Pharma Letter2h
Wegovy label should be extended, CHMP recommends
The European Medicines Agency’s (EMA) advisory committee the CHMP has adopted a positive opinion for a label update of Danish ...
Multiple Strong Catalysts And Attractive Valuation Make Novo Nordisk A Buy
Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.
The Pharma Letter1d
Novo Nordisk CEO to face Senate questions amid pricing controversy
Novo Nordisk is under pressure over US drug prices as CEO Lars Fruergaard Jørgensen prepares to testify before the Senate ...
mashviral2d
GLP-1 Tablets Set to Transform Weight-Loss Procedures
The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...
WebMD2d
Considering Zepbound in Vials? Here Are Some Starter Tips
The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
Daily Montanan3d
Why millions are trying FDA-authorized alternatives to weight loss drugs
Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...
Kate Moss’s sister Lottie claims she had a seizure on Ozempic. An expert weighs in on the importance of using these medications properly.
Model Lottie Moss is speaking out against the use of diabetes medication for weight loss after she allegedly overdosed on ...